Cheng‐Xi Wei

538 total citations
25 papers, 441 citations indexed

About

Cheng‐Xi Wei is a scholar working on Molecular Biology, Organic Chemistry and Cell Biology. According to data from OpenAlex, Cheng‐Xi Wei has authored 25 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Cell Biology. Recurrent topics in Cheng‐Xi Wei's work include Endoplasmic Reticulum Stress and Disease (5 papers), MicroRNA in disease regulation (4 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (3 papers). Cheng‐Xi Wei is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (5 papers), MicroRNA in disease regulation (4 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (3 papers). Cheng‐Xi Wei collaborates with scholars based in China and Mongolia. Cheng‐Xi Wei's co-authors include Guo-Hua Gong, Ming Bian, Feng-Mao An, YU Li-jun, Yu Wang, Xian‐Qing Deng, Zhe‐Shan Quan, Di Wang, Yu Wang and Chuan Hu and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and European Journal of Medicinal Chemistry.

In The Last Decade

Cheng‐Xi Wei

23 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng‐Xi Wei China 11 279 183 96 73 27 25 441
Charles K. Davis United States 12 175 0.6× 69 0.4× 22 0.2× 95 1.3× 16 0.6× 19 379
Makoto Shimozawa Japan 14 225 0.8× 38 0.2× 29 0.3× 80 1.1× 40 1.5× 27 525
Zhiqing Sun China 7 132 0.5× 59 0.3× 37 0.4× 32 0.4× 24 0.9× 12 303
Mohamad‐Reza Aghanoori Canada 13 380 1.4× 106 0.6× 23 0.2× 93 1.3× 45 1.7× 20 626
Xiongzhi Quan China 8 183 0.7× 74 0.4× 38 0.4× 74 1.0× 26 1.0× 12 341
Chandan K. Sen United States 7 179 0.6× 27 0.1× 70 0.7× 41 0.6× 17 0.6× 9 441
Hiromi Koma Japan 8 186 0.7× 48 0.3× 19 0.2× 45 0.6× 45 1.7× 16 353
Linlin Jing China 12 370 1.3× 101 0.6× 20 0.2× 21 0.3× 30 1.1× 18 627
Aiying Du China 12 323 1.2× 42 0.2× 54 0.6× 20 0.3× 37 1.4× 14 472
Yajun Li China 9 186 0.7× 79 0.4× 12 0.1× 38 0.5× 44 1.6× 14 334

Countries citing papers authored by Cheng‐Xi Wei

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Xi Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Xi Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Xi Wei more than expected).

Fields of papers citing papers by Cheng‐Xi Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Xi Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Xi Wei. The network helps show where Cheng‐Xi Wei may publish in the future.

Co-authorship network of co-authors of Cheng‐Xi Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Xi Wei. A scholar is included among the top collaborators of Cheng‐Xi Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Xi Wei. Cheng‐Xi Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Cheng‐Xi, et al.. (2023). A Word Difficulty Classification Research Based on K-Means Method. Highlights in Science Engineering and Technology. 70. 215–222.
2.
Xue, Bai, Qianqian Ma, Ming Bian, et al.. (2023). Synthesis, molecular docking studies of formononetin derivatives as potent Bax agonists for anticancer activity. Natural Product Research. 39(3). 423–437. 8 indexed citations
3.
Qu, Qi‐Xing, et al.. (2022). Cross-Domain Transfer Learning Prediction of COVID-19 Popular Topics Based on Knowledge Graph. Future Internet. 14(4). 103–103.
4.
Li, Xiang, Cheng‐Xi Wei, Lan Hong, et al.. (2021). Src-IL-18 signaling regulates the secretion of atrial natriuretic factor in hypoxic beating rat atria. Kardiologia Polska. 79(9). 972–979. 1 indexed citations
5.
Liu, Jia, Junfei Zhang, Guo-Hua Gong, Bin Zhang, & Cheng‐Xi Wei. (2020). Therapeutic Effect of Mongolian Medicine RuXian‐I on Hyperplasia of Mammary Gland Induced by Estrogen/Progesterone through CRYAB‐Promoted Apoptosis. Evidence-based Complementary and Alternative Medicine. 2020(1). 5707106–5707106. 5 indexed citations
6.
Wang, Yilin, Yu Wang, Cheng‐Xi Wei, et al.. (2020). Trapidil determines the fate of RHF rats through inhibition of ER stress. Archives of Pharmacal Research. 43(4). 409–420. 2 indexed citations
7.
Zhang, Junfei, Jia Liu, Guo-Hua Gong, Bin Zhang, & Cheng‐Xi Wei. (2019). Mongolian Medicine RuXian-I Treatment of Estrogen-Induced Mammary Gland Hyperplasia in Rats Related to TCTP Regulating Apoptosis. Evidence-based Complementary and Alternative Medicine. 2019. 1–10. 8 indexed citations
8.
Gong, Guo-Hua, Feng-Mao An, Yu Wang, et al.. (2018). Comprehensive Circular RNA Profiling Reveals the Regulatory Role of the CircRNA-0067835/miR-155 Pathway in Temporal Lobe Epilepsy. Cellular Physiology and Biochemistry. 51(3). 1399–1409. 53 indexed citations
9.
10.
Gong, Guo-Hua, Feng-Mao An, Yu Wang, et al.. (2018). MiR-153 regulates expression of hypoxia-inducible factor-1α in refractory epilepsy. Oncotarget. 9(9). 8542–8547. 20 indexed citations
11.
12.
Sun, Jinfeng, Wei Zhou, Cheng‐Xi Wei, et al.. (2018). A new benzofuran from Artemisia halodendron Turcz. ex Bess.. Natural Product Research. 33(2). 226–232. 9 indexed citations
13.
Gong, Guo-Hua, Feng-Mao An, Yu Wang, et al.. (2017). miR-15b represses BACE1 expression in sporadic Alzheimer’s disease. Oncotarget. 8(53). 91551–91557. 51 indexed citations
14.
15.
An, Feng-Mao, Guo-Hua Gong, Yu Wang, et al.. (2017). MiR-124 acts as a target for Alzheimer’s disease by regulating BACE1. Oncotarget. 8(69). 114065–114071. 106 indexed citations
16.
Wang, Yu, Sun Ying, Yao Fu, et al.. (2017). Calumenin relieves cardiac injury by inhibiting ERS-initiated apoptosis during viral myocarditis.. PubMed. 10(7). 7277–7284. 11 indexed citations
17.
Gong, Guo-Hua, et al.. (2013). Anticonvulsant Activity of 2-(Substituted-imino)thiazolidin-4-ones. Drug Research. 64(1). 5–9. 7 indexed citations
18.
Sun, Xian‐Yu, Chuan Hu, Xian‐Qing Deng, et al.. (2010). Synthesis and anti-inflammatory activity evaluation of some novel 6-alkoxy(phenoxy)-[1,2,4]triazolo[3,4-a]phthalazine-3-amine derivatives. European Journal of Medicinal Chemistry. 45(11). 4807–4812. 38 indexed citations
19.
Wei, Cheng‐Xi, et al.. (2009). Synthesis and Evaluation on Anticonvulsant and Antidepressant Activities of 5‐Alkoxy‐tetrazolo[1,5‐a]quinazolines. Archiv der Pharmazie. 342(11). 671–675. 32 indexed citations
20.
Wei, Cheng‐Xi, et al.. (2007). Synthesis of 2‐Substituted‐7‐heptyloxy‐4,5‐dihydro‐[1,2,4]‐triazolo[4,3‐a]quinolin‐1(2H)‐ones with Anticonvulsant Activity. Archiv der Pharmazie. 340(9). 491–495. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles K. Davis Breakdown of academic impact, for papers by Makoto Shimozawa Breakdown of academic impact, for papers by Zhiqing Sun Breakdown of academic impact, for papers by Mohamad‐Reza Aghanoori Breakdown of academic impact, for papers by Xiongzhi Quan Breakdown of academic impact, for papers by Chandan K. Sen Breakdown of academic impact, for papers by Hiromi Koma Breakdown of academic impact, for papers by Linlin Jing Breakdown of academic impact, for papers by Aiying Du Breakdown of academic impact, for papers by Yajun Li
Rankless by CCL
2026